Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects.

Summary: To evaluate the potential drug-drug interaction (DDI), safety and tolerability of fuzuloparib co-administered with a moderate CYP3A inducer efavirenz in healthy male subjects. Eighteen healthy male subjects were enrolled in a single-center, single-arm, open-label, fixed-sequence study. Fuzu...

Full description

Bibliographic Details

Published in:	Investigational New Drugs Vol. 41; no. 2; pp. 276 - 284
Main Authors:	Hu, Linlin, Dou, Ting, Sun, Qiuyue, Tang, Lu, Cai, Mingmin, Qian, Wei, Wang, Huiping
Format:	clinical trial research tables/charts Journal Article
Published:	Springer Nature Apr2023
Online Access:	View this record in EBSCOhost